Gabriel Tremblay

649 total citations
84 papers, 425 citations indexed

About

Gabriel Tremblay is a scholar working on Hematology, Oncology and Economics and Econometrics. According to data from OpenAlex, Gabriel Tremblay has authored 84 papers receiving a total of 425 indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Hematology, 30 papers in Oncology and 14 papers in Economics and Econometrics. Recurrent topics in Gabriel Tremblay's work include Multiple Myeloma Research and Treatments (16 papers), Cancer Treatment and Pharmacology (14 papers) and Health Systems, Economic Evaluations, Quality of Life (13 papers). Gabriel Tremblay is often cited by papers focused on Multiple Myeloma Research and Treatments (16 papers), Cancer Treatment and Pharmacology (14 papers) and Health Systems, Economic Evaluations, Quality of Life (13 papers). Gabriel Tremblay collaborates with scholars based in United States, United Kingdom and Canada. Gabriel Tremblay's co-authors include Anna Forsythe, Andrew Briggs, Corey Pelletier, David Chandiwana, Patrick Daniele, Joseph C. Cappelleri, Jaclyn Hearnden, Adrian Rabe, Hoyee Leong and Qayyim Said and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Gabriel Tremblay

79 papers receiving 407 citations

Peers

Gabriel Tremblay

HEMAT

ONCOL

PRM

Thuan V. Tran Vietnam

Dawn Lee United Kingdom

John Waller United Kingdom

Saling Huang United States

Michael Steinberg United States

Bernard Tawfik United States

Johan Liwing Sweden

Katharine Batt United States

Sarah S. Burns United States

Colleen Lewis United States

Thuan V. Tran Vietnam

Gabriel Tremblay

94 ×0.8

HEMAT

168 ×1.6

ONCOL

81 ×1.0

90 ×1.2

PRM

23 ×0.4

Citations per year, relative to Gabriel Tremblay Gabriel Tremblay (= 1×) peers Thuan V. Tran

Countries citing papers authored by Gabriel Tremblay

Since Specialization

Citations

This map shows the geographic impact of Gabriel Tremblay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gabriel Tremblay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gabriel Tremblay more than expected).

Fields of papers citing papers by Gabriel Tremblay

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gabriel Tremblay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gabriel Tremblay. The network helps show where Gabriel Tremblay may publish in the future.

Co-authorship network of co-authors of Gabriel Tremblay

This figure shows the co-authorship network connecting the top 25 collaborators of Gabriel Tremblay. A scholar is included among the top collaborators of Gabriel Tremblay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gabriel Tremblay. Gabriel Tremblay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sharif, Behnam, Gabriel Tremblay, Victoria M. Raymond, et al.. (2024). Population health outcomes of blood-based screening for colorectal cancer in comparison to current screening modalities: insights from a discrete-event simulation model incorporating longitudinal adherence. Journal of Medical Economics. 27(1). 991–1002. 1 indexed citations

Heeg, Bart, Gabriel Tremblay, Ofir Harari, et al.. (2023). Bayesian hierarchical model-based network meta-analysis to overcome survival extrapolation challenges caused by data immaturity. Journal of Comparative Effectiveness Research. 12(3). e220159–e220159. 1 indexed citations

Park, Jay, Behnam Sharif, Ofir Harari, et al.. (2022). Economic Evaluation of Cost and Time Required for a Platform Trial vs Conventional Trials. JAMA Network Open. 5(7). e2221140–e2221140. 25 indexed citations

Malfertheiner, Peter, Steven F. Moss, Patrick Daniele, et al.. (2022). Potassium-Competitive Acid Blocker and Proton Pump Inhibitor–Based Regimens for First-Line Helicobacter pylori Eradication: A Network Meta-Analysis. SHILAP Revista de lepidopterología. 1(5). 824–834. 14 indexed citations

Daniele, Patrizia, et al.. (2022). POSB311 Reviewing the Use of Matching Adjusted Indirect Comparisons in Health Technology Assessment Submissions. Value in Health. 25(1). S204–S204.

Tremblay, Gabriel, et al.. (2021). PCN82 Cost-Effectiveness of Once Weekly Selinexor-Bortezomib-Dexamethasone (XVD) in Previously Treated Multiple Myeloma (MM). Value in Health. 24. S34–S34.

Tremblay, Gabriel, et al.. (2019). PSY4 THE USE OF EQ-5D VISUAL ANALOG SCALE (EQ-VAS) IN DISEASES AREAS WHERE EQ-5D IS INSENSITIVE TO CHANGES IN THE DISEASE STATUS: THE CASE OF LIPODYSTROPHY. Value in Health. 22. S901–S901. 1 indexed citations

Punekar, Yogesh, Na Guo, Gabriel Tremblay, et al.. (2019). Improving access to antiretrovirals in China: economic analyses of dolutegravir in HIV-1 patients. Cost Effectiveness and Resource Allocation. 17(1). 26–26. 4 indexed citations

Tremblay, Gabriel, et al.. (2018). Cost-Effectiveness Analysis of Midostaurin (MIDO) With Standard of Care (SOC) for Acute Myeloid Leukemia (AML) in Canada. Value in Health. 21. S28–S29. 1 indexed citations

10.

Jones, Thomas V., et al.. (2018). PSY19 - USING A BAYESIAN NETWORK META-ANALYSIS (NMA) TO COMPARE FERRIC MALTOL TO TREATMENTS FOR IRON DEFICIENCY AND IRON DEFICIENCY ANAEMIA EXCLUDING CHF AND CKD PATIENTS. Value in Health. 21. S439–S439. 1 indexed citations

11.

Tremblay, Gabriel, Menaka Bhor, Anuja Roy, et al.. (2017). Cost-Consequence Model Comparing Eltrombopag and Romiplostim for Pediatric Patients with Previously-Treated Chronic Immune Thrombocytopenia. Blood. 130. 2146–2146. 1 indexed citations

12.

Forsythe, Anna, Anuja Roy, Menaka Bhor, et al.. (2017). Benefit-Risk Comparison in Patients with Immune Thrombocytopenia (ITP) Receiving Eltrombopag or Romiplostim: Real World Evidence (RWE) from 26 Hospital Institutions. Blood. 130. 3409–3409. 1 indexed citations

13.

Hudgens, Stacie, et al.. (2016). Real-World Evidence on Health States Utilities in in Metastatic Breast Cancer Patients: Data from a Retrospective Patient Record Form Study and A Cross-Sectional Patient Survey. Value in Health. 19(3). A157–A157. 3 indexed citations

14.

Tremblay, Gabriel, et al.. (2016). Budget Impact and Incremental Survival Benefit of Using Lenvatinib as a Treatment for Radioactive Iodine Refractory Differentiated Thyroid Cancer in Russia. Value in Health. 19(3). A143–A143. 1 indexed citations

15.

Tremblay, Gabriel, et al.. (2015). Matching-Adjusted Indirect Treatment Comparison And Survival Extrapolation In Radioiodine-Refractory Differentiated Thyroid Cancer (Rai-Refractory Dtc): Updated Analysis. Value in Health. 18(7). A435–A435. 2 indexed citations

16.

Tremblay, Gabriel, et al.. (2015). Incremental Quality Adjusted Life Years (Qaly) Analysis in Absence of Head to Head and Health Related Quality of Life (Hrqol) Data: a Case Study in Thyroid Cancer. Value in Health. 18(7). A707–A707. 2 indexed citations

17.

Tremblay, Gabriel, et al.. (2015). Cost Effectiveness Analysis of Eribulin Mesylate (Halaven®) as a Treatment for Metastatic Breast Cancer in Mexico. Value in Health. 18(7). A822–A822. 1 indexed citations

18.

Tremblay, Gabriel, et al.. (2014). Economic Burden of Chemotherapy Related Toxicities in Third Line Metastatic Breast Cancer Patients. Value in Health. 17(7). A628–A628. 2 indexed citations

19.

Hudgens, Stacie, Andrew Briggs, Gabriel Tremblay, Anna Forsythe, & Andrew Lloyd. (2014). Comparison of Methods to Estimate Health State Utilities in Metastatic Breast Cancer (MBC). Value in Health. 17(7). A557–A557. 8 indexed citations

20.

Tremblay, Gabriel, et al.. (1996). Human breast cancer: genetic alterations in the MET gene region.. PubMed. 19(4). 222–30. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact